SPL 4.40% 9.5¢ starpharma holdings limited

Merck’s anti-viral development., page-2

  1. 3,382 Posts.
    lightbulb Created with Sketch. 808
    Even one of our partners are doing human clinical trials for COVID-19 therapies (treatment). Zero comments so far …

    • A human trial for an oral antiviral
    • Possible FDA authorisation 2H 2021
    • US Government orders pending
    • Massive BARDA grant pending
    • Established licencing agreements for manufacture
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.004(4.40%)
Mkt cap ! $39.17M
Open High Low Value Volume
9.2¢ 9.6¢ 9.2¢ $81.30K 864.2K

Buyers (Bids)

No. Vol. Price($)
1 28056 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 1285 1
View Market Depth
Last trade - 16.10pm 26/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.